| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
81,708 |
76,735 |
$9.34M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
72,558 |
65,133 |
$8.75M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
81,939 |
71,497 |
$6.58M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
44,229 |
38,019 |
$5.96M |
| 70450 |
Computed tomography, head or brain; without contrast material |
20,282 |
17,909 |
$4.99M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
11,545 |
9,999 |
$2.88M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,684 |
4,122 |
$1.81M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
20,119 |
19,160 |
$1.80M |
| 80053 |
Comprehensive metabolic panel |
142,769 |
121,515 |
$1.72M |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
3,498 |
2,976 |
$929K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
3,649 |
3,123 |
$923K |
| G0378 |
Hospital observation service, per hour |
10,873 |
4,332 |
$727K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
5,643 |
3,664 |
$614K |
| 84443 |
Thyroid stimulating hormone (TSH) |
29,505 |
27,179 |
$581K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,231 |
1,354 |
$578K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,406 |
1,210 |
$549K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,256 |
2,007 |
$535K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,051 |
2,846 |
$523K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
7,403 |
2,642 |
$522K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
4,547 |
2,011 |
$469K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
143,745 |
119,337 |
$464K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
7,955 |
2,656 |
$444K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
4,022 |
2,207 |
$359K |
| 80061 |
Lipid panel |
29,132 |
27,101 |
$358K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,932 |
3,741 |
$342K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,724 |
1,453 |
$298K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,993 |
1,399 |
$292K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
20,906 |
17,421 |
$268K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
12,182 |
11,013 |
$257K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
558 |
444 |
$210K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
18,145 |
16,692 |
$188K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
26,244 |
20,373 |
$188K |
| 83605 |
|
38,124 |
30,964 |
$185K |
| H2020 |
Therapeutic behavioral services, per diem |
1,279 |
233 |
$182K |
| 36415 |
Collection of venous blood by venipuncture |
127,953 |
103,466 |
$171K |
| 70496 |
|
652 |
565 |
$169K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,760 |
1,398 |
$167K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
10,184 |
8,628 |
$167K |
| 70491 |
|
556 |
465 |
$165K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,343 |
1,172 |
$164K |
| 84484 |
|
47,595 |
34,892 |
$158K |
| 93017 |
|
1,811 |
1,580 |
$151K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,633 |
1,404 |
$143K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
830 |
727 |
$143K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12,738 |
7,945 |
$142K |
| 84439 |
|
8,954 |
8,219 |
$141K |
| 11045 |
|
377 |
156 |
$134K |
| 76642 |
|
1,079 |
966 |
$129K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,934 |
2,692 |
$128K |
| 85027 |
|
21,017 |
18,039 |
$128K |
| 71046 |
Radiologic examination, chest; 2 views |
18,133 |
16,587 |
$123K |
| 93458 |
|
150 |
118 |
$123K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
54,635 |
46,493 |
$120K |
| S9472 |
Cardiac rehabilitation program, non-physician provider, per diem |
1,442 |
200 |
$117K |
| 80320 |
|
8,688 |
7,193 |
$109K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
2,186 |
1,981 |
$108K |
| 93798 |
|
1,809 |
285 |
$108K |
| 71045 |
Radiologic examination, chest; single view |
29,423 |
25,720 |
$104K |
| 72131 |
|
1,782 |
1,540 |
$97K |
| 71250 |
|
1,323 |
1,185 |
$96K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
451 |
392 |
$93K |
| 93970 |
|
654 |
572 |
$92K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
4,977 |
4,478 |
$91K |
| 77334 |
|
264 |
204 |
$90K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
925 |
895 |
$86K |
| 97161 |
|
1,831 |
1,577 |
$86K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
954 |
830 |
$83K |
| 12001 |
|
532 |
469 |
$81K |
| 93971 |
|
1,347 |
1,172 |
$79K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
7,435 |
6,546 |
$78K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
913 |
841 |
$78K |
| 82607 |
|
5,198 |
4,585 |
$77K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
4,934 |
4,441 |
$73K |
| 86900 |
|
3,832 |
3,104 |
$67K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
47,675 |
40,948 |
$65K |
| 82728 |
|
3,380 |
2,999 |
$62K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
460 |
413 |
$62K |
| 71271 |
|
466 |
431 |
$62K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,781 |
5,934 |
$61K |
| 95911 |
|
246 |
219 |
$59K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
484 |
409 |
$59K |
| 77336 |
|
695 |
326 |
$57K |
| 86803 |
|
2,525 |
2,238 |
$57K |
| 10060 |
|
335 |
269 |
$54K |
| G0382 |
Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
644 |
636 |
$54K |
| 93975 |
|
625 |
489 |
$53K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
123 |
95 |
$53K |
| 97165 |
|
1,135 |
960 |
$52K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
367 |
332 |
$52K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,233 |
1,069 |
$50K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
102 |
70 |
$50K |
| 95886 |
|
856 |
771 |
$49K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
4,846 |
4,483 |
$47K |
| 76830 |
Ultrasound, transvaginal |
872 |
752 |
$46K |
| 94060 |
|
548 |
485 |
$46K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,803 |
2,110 |
$45K |
| 86850 |
|
3,540 |
2,894 |
$45K |
| 76536 |
|
473 |
435 |
$45K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,270 |
1,197 |
$44K |
| 87088 |
|
7,463 |
6,616 |
$42K |
| 86140 |
|
4,707 |
3,547 |
$42K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
36,507 |
29,839 |
$42K |
| 81001 |
|
51,729 |
46,138 |
$42K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
440 |
433 |
$42K |
| 96367 |
|
738 |
507 |
$40K |
| 76770 |
|
281 |
249 |
$40K |
| 83880 |
|
9,533 |
7,528 |
$39K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,516 |
449 |
$39K |
| 73700 |
|
357 |
304 |
$38K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
1,599 |
228 |
$36K |
| 83540 |
|
3,524 |
3,081 |
$36K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,871 |
1,650 |
$36K |
| 83735 |
|
13,749 |
10,614 |
$35K |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
763 |
621 |
$35K |
| 70498 |
|
591 |
520 |
$34K |
| 87081 |
|
1,834 |
1,732 |
$33K |
| 86038 |
|
1,362 |
1,187 |
$32K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,907 |
2,683 |
$32K |
| 88142 |
|
1,755 |
1,692 |
$32K |
| 95913 |
|
127 |
106 |
$31K |
| 86703 |
|
1,123 |
1,006 |
$30K |
| 97014 |
|
1,044 |
354 |
$29K |
| 82746 |
|
4,017 |
3,563 |
$29K |
| 84153 |
|
1,583 |
1,444 |
$29K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
29,811 |
24,129 |
$29K |
| 90714 |
|
1,909 |
1,581 |
$28K |
| 87070 |
|
2,546 |
2,012 |
$28K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
516 |
455 |
$27K |
| 94729 |
|
404 |
368 |
$27K |
| 83550 |
|
3,080 |
2,712 |
$26K |
| 72128 |
|
721 |
633 |
$26K |
| 70486 |
|
989 |
841 |
$26K |
| 12002 |
|
170 |
142 |
$26K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
1,591 |
1,522 |
$25K |
| 82570 |
|
2,950 |
2,668 |
$25K |
| 93308 |
|
144 |
126 |
$25K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
710 |
239 |
$25K |
| 77066 |
Tomosynthesis, mammo |
711 |
640 |
$25K |
| 74174 |
|
111 |
93 |
$24K |
| 72100 |
|
1,443 |
1,280 |
$24K |
| 86592 |
|
1,509 |
1,330 |
$24K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
49 |
37 |
$24K |
| 83970 |
|
1,000 |
884 |
$24K |
| 83516 |
|
902 |
553 |
$23K |
| 74018 |
|
773 |
662 |
$23K |
| 83690 |
|
26,608 |
23,198 |
$23K |
| J0897 |
Injection, denosumab, 1 mg |
25 |
12 |
$23K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
81 |
41 |
$22K |
| 73130 |
|
2,398 |
2,033 |
$22K |
| 85610 |
|
8,790 |
6,916 |
$22K |
| 82805 |
|
697 |
575 |
$21K |
| 96415 |
|
212 |
117 |
$21K |
| 73030 |
|
2,341 |
1,954 |
$21K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,386 |
1,046 |
$21K |
| 93880 |
|
318 |
285 |
$20K |
| 77065 |
Tomosynthesis, mammo |
611 |
498 |
$20K |
| 73630 |
|
2,571 |
2,223 |
$20K |
| 73502 |
|
1,530 |
1,274 |
$19K |
| 73562 |
|
1,674 |
1,463 |
$19K |
| 84702 |
|
1,872 |
1,469 |
$19K |
| 94726 |
|
297 |
276 |
$19K |
| 87077 |
|
2,521 |
2,082 |
$19K |
| 72141 |
|
135 |
120 |
$19K |
| 80076 |
|
1,644 |
1,386 |
$19K |
| 87340 |
|
1,105 |
957 |
$19K |
| 12011 |
|
128 |
112 |
$19K |
| 73610 |
|
3,244 |
2,698 |
$18K |
| 97535 |
Self-care/home management training, each 15 minutes |
824 |
508 |
$18K |
| 74178 |
|
65 |
58 |
$17K |
| 80346 |
|
894 |
860 |
$17K |
| A0425 |
Ground mileage, per statute mile |
1,476 |
1,233 |
$17K |
| 80074 |
|
874 |
763 |
$17K |
| 90677 |
|
71 |
62 |
$17K |
| 84403 |
|
809 |
725 |
$17K |
| 90686 |
|
1,130 |
1,051 |
$17K |
| 93923 |
|
238 |
220 |
$16K |
| 72040 |
|
532 |
479 |
$16K |
| 73560 |
|
1,507 |
1,274 |
$16K |
| 84550 |
|
2,214 |
2,003 |
$15K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
59 |
56 |
$15K |
| 86901 |
|
3,792 |
3,104 |
$15K |
| 86039 |
|
885 |
788 |
$15K |
| 20610 |
|
97 |
68 |
$14K |
| 80143 |
|
8,775 |
7,301 |
$14K |
| 86787 |
|
580 |
504 |
$14K |
| 86431 |
|
818 |
728 |
$14K |
| 85652 |
|
2,985 |
2,336 |
$14K |
| 87522 |
Neg quan hep c or qual rna |
390 |
323 |
$13K |
| 82077 |
|
5,231 |
4,138 |
$13K |
| 81003 |
|
9,459 |
8,566 |
$13K |
| 84146 |
|
619 |
549 |
$12K |
| 80164 |
|
1,370 |
1,104 |
$12K |
| 77300 |
|
62 |
51 |
$12K |
| 83001 |
|
590 |
532 |
$12K |
| 87210 |
|
1,620 |
1,419 |
$11K |
| 96376 |
|
3,547 |
1,978 |
$11K |
| 86403 |
|
683 |
558 |
$11K |
| 86762 |
|
550 |
481 |
$11K |
| 84630 |
|
709 |
657 |
$11K |
| 85378 |
|
3,143 |
2,748 |
$11K |
| 80364 |
|
976 |
943 |
$11K |
| 82962 |
|
8,622 |
4,285 |
$10K |
| 88112 |
|
411 |
326 |
$10K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
109 |
105 |
$10K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
1,090 |
975 |
$10K |
| 36591 |
|
424 |
242 |
$10K |
| 85651 |
|
1,838 |
1,375 |
$10K |
| 90832 |
Psychotherapy, 30 minutes with patient |
123 |
83 |
$10K |
| 88304 |
|
585 |
480 |
$10K |
| 73590 |
|
1,395 |
1,144 |
$9K |
| 82043 |
|
1,674 |
1,565 |
$9K |
| 84100 |
|
2,740 |
1,999 |
$9K |
| 86317 |
|
513 |
457 |
$9K |
| 82525 |
|
459 |
424 |
$9K |
| 49083 |
|
23 |
12 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,090 |
2,570 |
$9K |
| 82550 |
|
3,655 |
2,722 |
$9K |
| 84481 |
|
666 |
605 |
$9K |
| 84425 |
|
768 |
718 |
$9K |
| C8908 |
Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral |
28 |
26 |
$9K |
| 84270 |
|
477 |
423 |
$8K |
| 73110 |
|
1,428 |
1,170 |
$8K |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
602 |
472 |
$8K |
| 82044 |
|
986 |
896 |
$8K |
| 86481 |
|
234 |
208 |
$8K |
| 82784 |
|
843 |
525 |
$8K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,633 |
2,425 |
$8K |
| 81002 |
|
7,297 |
2,849 |
$8K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
544 |
296 |
$8K |
| 80179 |
|
8,757 |
7,292 |
$7K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
408 |
331 |
$7K |
| 36430 |
|
92 |
55 |
$7K |
| 82670 |
|
278 |
242 |
$7K |
| 86376 |
|
400 |
339 |
$7K |
| 87186 |
|
1,180 |
859 |
$7K |
| 82248 |
|
2,025 |
1,733 |
$7K |
| 83002 |
|
426 |
375 |
$7K |
| 86003 |
|
340 |
199 |
$7K |
| 84134 |
|
591 |
538 |
$7K |
| 82533 |
|
401 |
323 |
$7K |
| 72110 |
|
206 |
198 |
$7K |
| 73552 |
|
896 |
738 |
$7K |
| 87040 |
|
3,764 |
1,672 |
$7K |
| 64415 |
|
38 |
27 |
$6K |
| 84703 |
|
6,425 |
5,211 |
$6K |
| 90715 |
|
429 |
367 |
$6K |
| 86706 |
|
277 |
245 |
$6K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
15 |
12 |
$6K |
| 92523 |
|
101 |
95 |
$6K |
| 86704 |
|
323 |
283 |
$6K |
| 87205 |
|
1,872 |
1,320 |
$6K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
515 |
384 |
$6K |
| 88307 |
|
101 |
85 |
$5K |
| 86200 |
|
315 |
275 |
$5K |
| 84520 |
|
741 |
650 |
$5K |
| 84480 |
|
413 |
373 |
$5K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,918 |
1,764 |
$5K |
| 84590 |
|
425 |
395 |
$5K |
| 83695 |
|
400 |
393 |
$5K |
| 82140 |
|
823 |
615 |
$5K |
| G0008 |
Administration of influenza virus vaccine |
1,282 |
1,179 |
$5K |
| 82105 |
|
378 |
312 |
$4K |
| 81025 |
|
10,456 |
9,574 |
$4K |
| 73564 |
|
484 |
423 |
$4K |
| 76641 |
|
33 |
27 |
$4K |
| 84156 |
|
820 |
740 |
$4K |
| 86255 |
|
182 |
129 |
$4K |
| 95912 |
|
13 |
12 |
$4K |
| 90791 |
Psychiatric diagnostic evaluation |
32 |
29 |
$4K |
| 76981 |
|
48 |
41 |
$4K |
| 73080 |
|
544 |
469 |
$4K |
| 82565 |
|
861 |
750 |
$4K |
| 84436 |
|
1,091 |
918 |
$4K |
| 82947 |
|
1,061 |
726 |
$4K |
| 72120 |
|
106 |
92 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
542 |
500 |
$4K |
| 86618 |
|
239 |
183 |
$4K |
| 93922 |
|
57 |
54 |
$4K |
| 97597 |
|
30 |
24 |
$4K |
| 86235 |
|
197 |
130 |
$4K |
| 92526 |
|
83 |
55 |
$4K |
| 85730 |
|
2,786 |
2,286 |
$4K |
| 73521 |
|
218 |
198 |
$3K |
| 76870 |
|
82 |
66 |
$3K |
| J3490 |
Unclassified drugs |
133 |
61 |
$3K |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
20 |
12 |
$3K |
| 72050 |
|
93 |
82 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,428 |
5,036 |
$3K |
| 72170 |
|
898 |
784 |
$3K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
20 |
17 |
$3K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
34 |
24 |
$3K |
| 86225 |
|
175 |
149 |
$3K |
| 86923 |
|
118 |
57 |
$3K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
5,754 |
2,479 |
$3K |
| 73090 |
|
637 |
540 |
$3K |
| 77080 |
|
47 |
43 |
$3K |
| 88342 |
|
610 |
501 |
$3K |
| 73070 |
|
350 |
305 |
$3K |
| J1953 |
Injection, levetiracetam, 10 mg |
683 |
459 |
$3K |
| 83615 |
|
440 |
338 |
$3K |
| 85379 |
|
3,017 |
2,633 |
$3K |
| 94250 |
|
32 |
14 |
$3K |
| 83520 |
|
85 |
67 |
$2K |
| 87075 |
|
684 |
491 |
$2K |
| 95910 |
|
15 |
13 |
$2K |
| 83655 |
|
115 |
113 |
$2K |
| 97022 |
|
36 |
13 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
63 |
59 |
$2K |
| 80349 |
|
186 |
178 |
$2K |
| 74183 |
|
13 |
13 |
$2K |
| 82785 |
|
158 |
134 |
$2K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
3,490 |
1,562 |
$2K |
| 95816 |
|
12 |
12 |
$2K |
| 72072 |
|
121 |
114 |
$2K |
| 76801 |
|
64 |
51 |
$2K |
| 73060 |
|
396 |
347 |
$2K |
| 73221 |
|
14 |
12 |
$2K |
| 80178 |
|
193 |
166 |
$2K |
| 86308 |
|
535 |
442 |
$2K |
| 87147 |
|
150 |
126 |
$2K |
| 97129 |
|
59 |
27 |
$2K |
| 94010 |
|
202 |
180 |
$2K |
| 90648 |
|
209 |
200 |
$2K |
| 95117 |
|
84 |
49 |
$2K |
| 84165 |
|
205 |
175 |
$2K |
| 81005 |
|
302 |
295 |
$2K |
| 71101 |
|
218 |
185 |
$2K |
| 96368 |
|
268 |
173 |
$2K |
| 84145 |
|
530 |
425 |
$2K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
13 |
13 |
$2K |
| S9445 |
Patient education, not otherwise classified, non-physician provider, individual, per session |
28 |
27 |
$2K |
| 81170 |
|
14 |
13 |
$1K |
| 78306 |
|
15 |
12 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
30,511 |
26,642 |
$1K |
| 85014 |
|
485 |
340 |
$1K |
| 88185 |
|
21 |
12 |
$1K |
| 86256 |
|
74 |
57 |
$1K |
| 82150 |
|
1,419 |
1,214 |
$1K |
| 82977 |
|
176 |
161 |
$1K |
| 82950 |
|
94 |
86 |
$1K |
| 86160 |
|
97 |
73 |
$1K |
| 86800 |
|
81 |
66 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
5,040 |
3,809 |
$1K |
| 94664 |
|
940 |
760 |
$1K |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
88 |
65 |
$1K |
| 81206 |
|
12 |
12 |
$1K |
| 82627 |
|
55 |
50 |
$1K |
| J3486 |
Injection, ziprasidone mesylate, 10 mg |
100 |
70 |
$1K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14 |
12 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,090 |
2,165 |
$1K |
| 90670 |
|
223 |
211 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
14 |
13 |
$1K |
| 84132 |
|
842 |
673 |
$1K |
| 80177 |
|
111 |
88 |
$965.49 |
| 87449 |
|
150 |
109 |
$928.78 |
| 80202 |
|
45 |
16 |
$887.58 |
| 86334 |
|
61 |
50 |
$880.65 |
| 80353 |
|
75 |
70 |
$852.16 |
| 82951 |
|
32 |
27 |
$833.64 |
| 72070 |
|
18 |
15 |
$827.33 |
| 93325 |
|
15 |
13 |
$820.57 |
| 82378 |
|
122 |
79 |
$809.40 |
| J1644 |
Injection, heparin sodium, per 1000 units |
2,252 |
977 |
$808.70 |
| 87045 |
|
68 |
56 |
$786.46 |
| 74022 |
|
73 |
60 |
$777.55 |
| 87634 |
|
754 |
666 |
$761.33 |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
424 |
270 |
$746.38 |
| 82103 |
|
57 |
51 |
$724.85 |
| 82553 |
|
69 |
58 |
$699.22 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
368 |
141 |
$683.74 |
| 84155 |
|
127 |
115 |
$681.81 |
| 80373 |
|
59 |
59 |
$667.81 |
| 85018 |
|
366 |
252 |
$665.52 |
| 97130 |
|
41 |
14 |
$662.32 |
| 80323 |
|
40 |
36 |
$659.75 |
| 90633 |
|
75 |
70 |
$653.80 |
| 80162 |
|
40 |
37 |
$624.53 |
| 84478 |
|
128 |
110 |
$619.72 |
| 82465 |
|
69 |
62 |
$616.36 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
543 |
427 |
$615.37 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
665 |
459 |
$595.07 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
989 |
655 |
$565.16 |
| 84466 |
|
74 |
60 |
$550.98 |
| 82010 |
|
693 |
558 |
$549.40 |
| 80050 |
General health panel |
312 |
271 |
$542.39 |
| 84460 |
|
68 |
61 |
$533.82 |
| J1453 |
Injection, fosaprepitant, 1 mg |
45 |
25 |
$532.50 |
| 88184 |
|
12 |
12 |
$528.95 |
| 86735 |
|
18 |
18 |
$528.21 |
| 85045 |
|
138 |
105 |
$521.54 |
| 80347 |
|
32 |
29 |
$514.35 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,312 |
1,102 |
$512.73 |
| 76775 |
|
13 |
12 |
$508.48 |
| G0009 |
Administration of pneumococcal vaccine |
271 |
240 |
$504.68 |
| 86880 |
|
29 |
24 |
$503.28 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
1,757 |
1,434 |
$498.72 |
| 90723 |
|
129 |
126 |
$483.30 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
873 |
690 |
$474.13 |
| G0296 |
Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) |
15 |
14 |
$467.21 |
| 86765 |
|
21 |
19 |
$433.81 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
5,201 |
4,095 |
$423.30 |
| 82330 |
|
35 |
30 |
$418.24 |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
34 |
12 |
$394.59 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
17,321 |
13,846 |
$390.94 |
| 87046 |
|
66 |
56 |
$387.43 |
| J2704 |
Injection, propofol, 10 mg |
7,868 |
4,225 |
$372.79 |
| 00731 |
|
336 |
275 |
$372.09 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
7,581 |
5,429 |
$371.03 |
| 00813 |
|
145 |
109 |
$359.26 |
| 00811 |
|
31 |
24 |
$359.26 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,017 |
731 |
$347.77 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
3,215 |
1,738 |
$338.84 |
| 73120 |
|
13 |
12 |
$335.32 |
| 90681 |
|
37 |
32 |
$311.60 |
| 87427 |
|
53 |
43 |
$310.20 |
| J2060 |
Injection, lorazepam, 2 mg |
1,817 |
1,353 |
$296.72 |
| 83525 |
|
18 |
13 |
$295.02 |
| C1769 |
Guide wire |
963 |
753 |
$289.58 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
1,041 |
551 |
$258.57 |
| 80051 |
|
53 |
43 |
$257.04 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,158 |
911 |
$256.28 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,146 |
804 |
$248.66 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,160 |
1,779 |
$246.85 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
23,221 |
20,172 |
$244.66 |
| 82652 |
|
14 |
12 |
$242.19 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
7,586 |
5,352 |
$230.52 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
16 |
13 |
$227.67 |
| J0574 |
Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine |
22 |
12 |
$224.94 |
| 80175 |
|
20 |
18 |
$224.91 |
| 87807 |
|
105 |
95 |
$224.28 |
| 83020 |
|
14 |
12 |
$212.93 |
| J1790 |
Injection, droperidol, up to 5 mg |
600 |
449 |
$192.05 |
| 82800 |
|
602 |
496 |
$188.68 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
138 |
135 |
$164.32 |
| 88341 |
|
30 |
25 |
$160.28 |
| 88173 |
|
36 |
24 |
$154.43 |
| J3410 |
Injection, hydroxyzine hcl, up to 25 mg |
44 |
40 |
$145.46 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
699 |
610 |
$140.44 |
| J1456 |
Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg |
18 |
12 |
$133.56 |
| 73620 |
|
14 |
13 |
$132.71 |
| 90694 |
|
22 |
20 |
$132.64 |
| 80176 |
|
12 |
12 |
$128.52 |
| 96417 |
|
204 |
130 |
$121.95 |
| V5266 |
Battery for use in hearing device |
15 |
14 |
$112.36 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
661 |
490 |
$112.26 |
| 80198 |
|
23 |
12 |
$98.58 |
| J3250 |
Injection, trimethobenzamide hcl, up to 200 mg |
25 |
14 |
$91.24 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
244 |
188 |
$88.72 |
| 93797 |
|
15 |
12 |
$82.45 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
4,374 |
3,237 |
$79.13 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
493 |
274 |
$76.91 |
| 29125 |
|
157 |
141 |
$66.07 |
| 89051 |
|
73 |
51 |
$63.67 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
350 |
347 |
$61.62 |
| J1940 |
Injection, furosemide, up to 20 mg |
568 |
394 |
$59.76 |
| 81015 |
|
18 |
15 |
$58.80 |
| 86694 |
|
16 |
14 |
$54.02 |
| 85384 |
|
49 |
38 |
$39.77 |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
48 |
37 |
$37.20 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
255 |
199 |
$36.90 |
| 80305 |
|
26 |
12 |
$35.53 |
| J1630 |
Injection, haloperidol, up to 5 mg |
134 |
83 |
$33.50 |
| J7605 |
Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms |
134 |
96 |
$24.99 |
| J7050 |
Infusion, normal saline solution, 250 cc |
637 |
412 |
$23.74 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
213 |
186 |
$23.40 |
| 80145 |
|
21 |
16 |
$21.42 |
| 84300 |
|
14 |
12 |
$18.82 |
| J1921 |
Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg |
101 |
85 |
$18.21 |
| J3480 |
Injection, potassium chloride, per 2 meq |
641 |
376 |
$17.99 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
571 |
444 |
$17.69 |
| J3360 |
Injection, diazepam, up to 5 mg |
15 |
14 |
$17.60 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
16 |
12 |
$17.35 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
618 |
493 |
$15.43 |
| 83037 |
|
122 |
115 |
$15.04 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
127 |
79 |
$9.93 |
| J3411 |
Injection, thiamine hcl, 100 mg |
26 |
12 |
$8.49 |
| J1939 |
Injection, bumetanide, 0.5 mg |
57 |
40 |
$8.22 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
2,306 |
1,667 |
$4.81 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
106 |
96 |
$4.78 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
176 |
107 |
$4.58 |
| J1836 |
Injection, metronidazole, 10 mg |
61 |
29 |
$4.28 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
285 |
256 |
$3.88 |
| Q0243 |
Injection, casirivimab and imdevimab, 2400 mg |
32 |
29 |
$0.27 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
196 |
188 |
$0.25 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
17 |
17 |
$0.15 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
15 |
12 |
$0.00 |
| 85576 |
|
17 |
13 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
973 |
832 |
$0.00 |
| C1889 |
Implantable/insertable device, not otherwise classified |
52 |
42 |
$0.00 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
183 |
173 |
$0.00 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
51 |
15 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
95 |
66 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
1,128 |
970 |
$0.00 |
| A4648 |
Tissue marker, implantable, any type, each |
222 |
168 |
$0.00 |
| J2305 |
Injection, nitroglycerin, 5 mg |
19 |
18 |
$0.00 |
| C9399 |
Unclassified drugs or biologicals |
72 |
59 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
29 |
27 |
$0.00 |
| 95012 |
|
18 |
14 |
$0.00 |
| 96411 |
|
18 |
13 |
$0.00 |
| 00790 |
|
25 |
13 |
$0.00 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
434 |
380 |
$0.00 |
| 85347 |
|
175 |
118 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
14 |
14 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
76 |
56 |
$0.00 |
| 00812 |
|
61 |
57 |
$0.00 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
127 |
109 |
$0.00 |
| C1729 |
Catheter, drainage |
76 |
42 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
15 |
12 |
$0.00 |
| 00400 |
|
34 |
26 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
66 |
52 |
$0.00 |
| G0330 |
Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room |
14 |
12 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
15 |
14 |
$0.00 |